JPT2 and esophageal squamous cell carcinoma: Overexpression HN1L decreased the apoptosis level of ESCC cells under treatment of Docetaxel, and reducing HN1L expression increased the level of Docetaxel-induced apoptosis (Fig. 4E, F).